Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics (BIPass II)
Clinical trial NCT05550805 · COMPLETED
Trial details
- NCT number
- NCT05550805
- Sponsor
- Qilu Hospital of Shandong University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-01
- Primary completion
- 2022-03-01
- Enrollment
- 5822
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.